The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

O.A. Gromova

Federal Research Center «Computer Science and Control»

I.Yu. Torshin

Federal Research Center «Computer Science and Control»

M.V. Putilina

Pirogov Russian National Research Medical University

V.A. Semenov

Kemerovo State Medical University

K.V. Rudakov

Institute of Pharmacoinformatics;
Center for Big Data Storage and Analysis of Moscow State University

Choice of neuroprotective therapy regimens in patients with chronic cerebral ischemia, taking into account the synergy of drug interactions

Authors:

O.A. Gromova, I.Yu. Torshin, M.V. Putilina, V.A. Semenov, K.V. Rudakov

More about the authors

Views: 9962

Downloaded: 192


To cite this article:

Gromova OA, Torshin IYu, Putilina MV, Semenov VA, Rudakov KV. Choice of neuroprotective therapy regimens in patients with chronic cerebral ischemia, taking into account the synergy of drug interactions. S.S. Korsakov Journal of Neurology and Psychiatry. 2020;120(8):42‑50. (In Russ.)
https://doi.org/10.17116/jnevro202012008142

Recommended articles:
The successful use of Cyto­flavin in the patient with postaveny syndrome. S.S. Korsakov Journal of Neurology and Psychiatry. 2023;(7):108-111
Difficulties in diagnosing the chro­nic course of tick-borne ence­phalitis in children. S.S. Korsakov Journal of Neurology and Psychiatry. 2023;(10):118-122

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation



We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.